| Insider | Febbo Phillip G. |
|---|---|
| Title | Chief Scientific & Med Officer |
| Transaction Date | Mar 6, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 10, 2026 |
| Shares Purchased | 29,603 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 146,949 |
| Derivative | No |
| Accession Number | 0001649245-26-000006 |
| Document | View SEC Filing |